The Role of Neurotransmitter Testing in Pediatric Behavioral Health

By: Larisa N. Gruer, RND, PhD

Has worked with Sabre Sciences for 18 years!

Clincial Director for the European Institute for Natural Health, LLC

Neurotransmitter testing has become an increasingly valuable tool for understanding and addressing behavioral challenges in children. After nearly two decades of clinical experience at the European Institute for Natural Health in Newport Beach, California, I have witnessed firsthand how a deeper examination of brain chemistry can transform both diagnosis and treatment outcomes for young patients struggling with mood, attention, and behavioral regulation.

Children with behavioral concerns are often quickly labeled with conditions such as ADHD, anxiety disorders, or oppositional behaviors. While these diagnoses can help guide care, they frequently overlook an underlying and highly influential factor: neurochemical balance.

Neurotransmitters—such as dopamine, serotonin, GABA, and norepinephrine—play a central role in regulating attention, emotional stability, impulse control, and sleep. When these systems are imbalanced, the resulting symptoms can closely mimic or intensify common behavioral conditions.

Traditional approaches tend to rely heavily on observation and standardized behavioral assessments. While these methods are important, they may not fully capture the biological roots of a child’s challenges. Neurotransmitter testing offers a more individualized perspective.

By analyzing specific biochemical markers, clinicians can determine whether symptoms stem from deficiencies, excesses, or dysregulation within key neurotransmitter systems. This insight enables a more targeted and personalized intervention strategy.

Learn About Testing

Over the years, I have worked with many families who arrived feeling frustrated after trying multiple therapies with limited success. In numerous cases, neurotransmitter testing revealed imbalances that had not previously been considered. For instance, a child experiencing impulsivity and hyperactivity may exhibit low dopamine levels, while another struggling with anxiety and emotional sensitivity may show reduced serotonin or GABA activity. These findings allow clinicians to move beyond symptom management and begin addressing underlying causes.

One of the most significant advantages of this approach is its support for more natural and integrative treatment options. Rather than relying solely on pharmaceutical interventions, care plans can incorporate targeted nutritional support, amino acid therapy, lifestyle modifications, and stress regulation techniques. This is particularly valuable for parents seeking gentler, more holistic approaches to their child’s health.

Additionally, neurotransmitter testing can improve treatment precision and reduce the trial-and-error process that is so common in behavioral care. When interventions are guided by objective data, progress is often more measurable and sustainable. Parents frequently report improvements not only in behavior, but also in sleep, mood, academic performance, and overall well-being.

It is also important to recognize that neurotransmitter balance is dynamic, especially in children whose brains are still developing. Early identification and intervention can have a lasting impact by helping to build a stronger neurological foundation during critical developmental periods. This proactive approach may reduce the risk of more severe challenges later in adolescence and adulthood.

In my clinical experience, integrating neurotransmitter testing into pediatric behavioral care represents a meaningful advancement. It helps bridge the gap between biology and behavior, providing families with clearer answers and more effective solutions. While no single tool can offer all the answers, neurotransmitter testing is a powerful component of a comprehensive, individualized approach to care.

Ultimately, every child deserves to be understood beyond their symptoms.

By examining the biochemical factors that influence behavior, we open the door to more compassionate, precise, and effective interventions—helping children not only manage their challenges but truly thrive.

Conclusion

Although neurotransmitter testing is not a standalone diagnostic tool, it represents a scientifically grounded approach to understanding the neurochemical foundations of behavioral challenges in children. When combined with clinical expertise and incorporated into a broader, integrative assessment, it has the potential to enhance diagnostic clarity and improve individualized treatment strategies—ultimately supporting better behavioral outcomes and overall well-being for both the child and their family.

Learn More About Dr Gruer